One of half a dozen Paul Mampilly-connected newsletters at Banyan Hill, this one is a “trading service” that attempts to pick a couple midsize stocks each month that have “true momentum” (which seems to be a qualitative assessment of the business prospects, not a market momentum measure).
↧
True Momentum
↧
Sniffing out Mampilly’s latest “True Momentum” Trade
Today we’ve got a bit of a quickie for you, mostly just because the clues that were dropped were extremely limited… but it also happens to be a stock I’ve looked at before, so I thought it was worth taking a second look today. Paul Mampilly over the weekend was peddling his True Momentum service […]
↧
↧
Revealing Stutman’s “Three Companies that are Leading the Charge to 5G”
Jason Stutman’s latest ad for his Technology and Opportunity newsletter ($39/yr, which means they’re really not making money on this unless they get you to upgrade to something else in the future) is yet one more attempt to get us excited because of the rising trend of 5G investment that he thinks will bring “skyrocketing […]
↧
Friday File: Earningspalooza Overload — Two Sells, Four Buys and a dozen updates
Earnings season is clobbering me with news once again this week, so there’s a lot to share… I’ll start with the actual transactions I made today, and move on to look at a dozen other stocks I own or am watching… buckle up! We’ll start with the one that probably most of you can’t easily […]
↧
Four (or Five) Stocks for the “World’s Best Business”
Today I thought I’d answer a reader question about a teaser that’s of particular interest to me — not because it’s particularly heavily marketed, I haven’t even seen the original ad or article our reader cites, but because I like the topic. Here’s the question posted by Irregular bunion132 recently: In a recent piece entitled […]
↧
↧
Matt McCall’s “300X Your Money” on Chinese Biotech Pitch
Matt McCall’s out with another high-priced promo letter that promises the potential for huge gains — this time, by finding the stocks that he thinks will benefit from China’s massive increase in health care spending in the years to come. The ad is for his Early Stage Investor, and he claims to be making a […]
↧
Three more “Secret” Stocks for this “50X” opportunity
Yesterday I started digging in to Matt McCall’s tease about a huge opportunity in Chinese biotech… and, as promised, today I’m finishing the job. The basic premise is that China is pushing to make biopharma a bigger part of its economy in both the current five-year plan and the “made in China 2025” plan, and […]
↧
“‘Cut & Paste’ Disease From Your Body”— what’s this “Living Software” Business from Dylan Jovine?
This article was originally published on November 5, 2018, we’re getting lots of questions so we’re popping it to the top of the page for you but it has not been updated or revised — the ad being covered appears to be almost identical to the ad that was running in the fall of 2018. […]
↧
What’s this “Founder’s share Certificate” for a Space Investment?
Ian Wyatt is out with a new ad for a “urgent briefing” that will be taking place today about a “secret billionaire investment”… and while the briefing hasn’t happened yet, so we’re not sure what the pitch will be, odds are good that he’s going to keep the “insider shares” secret and dangle a subscription […]
↧
↧
Friday File: Sad Lasers, Disappointing Hemp and too many Mutual Funds
Let’s start with the bad news… we got quarterly updates this week from Charlotte’s Web (CWEB.TO, CWBHF) and II-VI (IIVI), both stocks I’ve bought fairly recently (IIVI just a few weeks ago, CWEB a few months ago), and those are both in the red. Neither one hit a stop loss yet, but what did we […]
↧
“Immortality Switch”— What’s Kramer’s “$6 Anti-Aging Stock?”
For some reason, the investment newsletter audience (and their publishers) find “anti-aging” pitches quite appealing… maybe it’s because so many of us are reaching those “golden years” and wondering how to extend them without pain or poverty. I’m not quite in the “core” demographic yet at 49, but I’ve got the knees and hips of […]
↧
IPO Insider
High end monthly newsletter recommending IPOs, promoted as using a proprietary system to identify the best 10 or so newly public stocks to invest in during a given year. Spittler previously worked on International Speculator for Casey Research.
↧
“The Other Search Giant” teased by Justin Spittler
The folks at RiskHedge are out with a new IPO-focused newsletter called IPO Insider ($2,997/yr is the promoted price), aiming to find “Hidden IPOs for Extreme Wealth” using Justin Spittler’s “SONAR” system for identifying the best IPO opportunities. Spittler used to write for a newsletter or two for Doug Casey’s firm, we’ve covered a few […]
↧
↧
What’s the “Artificial Intelligence ‘Stealth ID’ Technology” Stock Being Teased by Outsider Club?
This article was originally published when we first saw the ads circulating, in April of 2019. The stock has since lost about 2/3 of its value, but we’re getting a lot more questions about it this week and the ad is circulating again, this time pitching it as a 50-cent “defense” stock that will double […]
↧
“Easily Make $104,000” from “Chaos in the Global Shipping Markets on January 1, 2020”
Christian DeHaemer’s Bull and Bust Report ($99/yr) is out with a pitch about “Chaos in the Global Shipping Markets” that has gotten the attention of a bunch of Gumshoe readers — and it is based on something real that’s happening, so I thought we’d dig in and take a quick look today. The spiel is, […]
↧
Friday File: Buying Risky Retail, Checking up on REITs
Not a lot of buying and selling going on this week, as the market continues to seem to be reacting only to the “thumbs up” or “thumbs down” sentiment over a possible Chinese trade deal, but I did find one stock to buy… and caught up on a few others that have been catching my […]
↧
2019 Turkey of the Year
Turn down the football game and bring out the pies, it’s that time again! Stock Gumshoe is mostly closed down for the holiday week, but we do have to continue our annual tradition of calling out our “Turkey of the Year” … so take a pause from arguing with your family and join us, won’t […]
↧
↧
Elon Musk’s Worst Nightmare – Unprepared for “Tesla Killer,” sez Casey Research
This ad started running late in 2018, and the article below was first published on February 4, 2019… the ad is sending a lot of questions our way this week and is almost entirely unchanged, and the article below is lightly updated to share some more recent news and developments. The promise in Dave Forest’s […]
↧
Jeff Brown’s “New CURE” Tease
I’ve gotten a big pile of questions about the latest teaser pitch from Jeff Brown, who is now taking credit for the rise of the CRISPR stocks and sees another big surge coming. And for what it’s worth, he was one of the early newsletter guys promoting the three primary CRISPR stocks a few years […]
↧
Cash Machine’s “Enroll in the Next 24 Hours” pitch for 8.53% Income Fund
I haven’t written about Bryan Perry’s Cash Machine newsletter in several years, and I know that a lot of Gumshoe readers are interested in income investments and dividends… so I thought this would be a good one to sniff out for you. The ad is for a subscription to his newsletter, of course (currently $49.95/yr, […]
↧